Convergence of immunometabolism and lung cancer therapy: redefining the tumor–immune interface
Abstract Surgery, chemotherapy, radiotherapy, and immune checkpoint blockade remain the mainstays of lung cancer treatment. Despite these approaches, lung cancer continues to be the second leading cause of cancer-related deaths worldwide. Recent insights into the metabolic reprogramming of lung tumo...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2026-02-01
|
| Серии: | European Journal of Medical Research |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s40001-026-04011-w |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|